Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)

• Egile Nagusiak: M. Sabaté (Egilea), X. Vidal (Egilea), E. Ballarin (Egilea), M. Rottenkolber (Egilea), S. Schmiedl (Egilea), B. Grave (Egilea), C. Huerta (Egilea), E. Martin-Merino (Egilea), D. Montero (Egilea), L. M. Leon-Muñoz (Egilea), C. Gasse (Egilea), N. Moore (Egilea), C. Droz (Egilea), R. Lassalle (Egilea), M. Aakjær (Egilea), M. Andersen (Egilea), M. L. De Bruin (Egilea), P. Souverein (Egilea), O. H. Klungel (Egilea), H. Gardarsdottir (Egilea), L. Ibáñez (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Aims: To describe and compare the adherence to different direct oral anticoagulants (DOACs) in eight European databases representing six countries.Methods: Longitudinal drug utilization study of new users (≥18 years) of DOACs (dabigatran, rivaroxaban, apixaban) with a diagnosis of non-valvular atria...